DEF: Nocera Inc. Schedules 2026 Shareholder Meeting

Nocera, Inc. has issued a definitive proxy statement detailing proposals for its 2026 Annual Meeting of Shareholders, including director elections, share authorization increases, and equity plan approvals.

Summary

• Nocera, Inc. is holding its 2026 Annual Meeting of Shareholders virtually on December 21, 2026.
• Key proposals include electing five directors, increasing authorized common stock from 66,666,667 to 2,000,000,000 shares, ratifying SFAI Malaysia PLT as auditors, approving new warrants, adopting the 2026 Equity Compensation Plan, authorizing reverse stock splits, and approving potential share issuances under an Equity Purchase Facility Agreement.
• The company is also seeking approval to amend its Articles of Incorporation to authorize a significant increase in the number of authorized shares.
• Shareholders of record as of October 16, 2026, are entitled to vote.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily focused on procedural matters for an upcoming shareholder meeting. While several proposals aim to increase flexibility and potential future capital, they do not immediately signal strong financial performance or growth.

Positives

• The company is proactively engaging shareholders for important corporate decisions.
• Proposals aim to provide greater financial and strategic flexibility for future operations, including potential financings and acquisitions.
• The adoption of a new Equity Compensation Plan is intended to attract, retain, and motivate key personnel.
• The company is seeking to maintain compliance with Nasdaq listing requirements through proposed actions like reverse stock splits and share issuance approvals.

Negatives

• The significant increase in authorized shares and potential for future share issuance could lead to substantial dilution for existing shareholders.
• The approval of the Equity Purchase Facility Agreement allows for potential issuance of shares at prices below Nasdaq's minimum bid price, which could be dilutive.
• The authorization for reverse stock splits, while aimed at compliance, can sometimes be perceived negatively by the market if not accompanied by fundamental improvements.

Risks

• Potential for significant dilution of existing shareholder equity due to the proposed increase in authorized shares and the Equity Purchase Facility Agreement.
• The company's reliance on future financings and potential share issuances to meet corporate needs.
• Maintaining compliance with Nasdaq listing requirements, particularly the minimum bid price, remains a challenge.
• The effectiveness of the proposed reverse stock split in achieving sustained compliance with Nasdaq's minimum bid price requirement is not guaranteed.

Future Outlook

The filing does not contain specific forward-looking financial guidance. However, proposals related to increasing authorized shares, approving new warrants, and the Equity Purchase Facility Agreement suggest a strategy to secure future capital and operational flexibility.

Management Comments

• The Board believes that Proposals 1 through 7 are in the best interests of the Company and its shareholders and recommends a vote consistent with the Boards recommendation for each proposal.
• The Board believes that restoring the authorized share count to 2,000,000,000 is in the best interests of the Company and its shareholders because the 1-for-30 reverse stock split that became effective July 6, 2026 proportionally reduced the authorized shares from approximately 2,000,000,000 to approximately 66,666,667, and the Company needs adequate authorized but unissued shares for future corporate purposes, including potential financings, acquisitions, equity compensation plans and other general corporate needs.
• The Board believes that the reverse stock split authorization is in the best interests of the Company and its shareholders because it would provide flexibility to address Nasdaqs minimum bid-price requirement and other continued listing requirements.
• The Board has determined that this proposal is in the best interests of the Company and its shareholders because it will enable the Company to comply with Nasdaq Listing Rule 5635(d), remove the Exchange Cap (as defined in the Proposal) under the EPFA, and satisfy its obligations under the EPFA.

Industry Context

StockSavvy.ai notes that Nocera's proposals, particularly the significant increase in authorized shares and the potential for dilutive issuances, are common strategies for companies seeking to maintain Nasdaq listing compliance and secure future funding. Competitors facing similar listing pressures often explore reverse stock splits and equity facilities.

Comparison to Industry Standards

• The proposed increase in authorized shares from approximately 66.7 million to 2 billion represents a substantial increase, far exceeding typical annual authorizations for many companies. This level of authorization is often seen in companies with aggressive growth or financing plans.
• The Equity Purchase Facility Agreement allowing up to $100 million in stock issuances, potentially below market price, is a financing tool used by some smaller public companies to access capital, though it carries significant dilution risk compared to traditional debt or equity offerings.
• The proposed 2026 Equity Compensation Plan, authorizing 3 million shares, is a standard mechanism for incentivizing employees and directors, with the number of shares reserved being a key metric for assessing potential dilution.

Corporate Governance

Related Party Transactions

• No related party transactions exceeding the disclosure threshold of $120,000 or one percent of average total assets were disclosed for the fiscal year 2025 or proposed.

Stakeholder Impact

• Shareholders: Potential for significant dilution of ownership percentage and voting power due to proposed share increases and equity issuances. Conversely, proposals aim to provide flexibility for future growth and compliance, potentially benefiting long-term shareholder value.
• Employees: The 2026 Equity Compensation Plan is designed to attract, retain, and motivate employees through equity incentives.
• Management: The proposals, particularly those related to financing and Nasdaq compliance, are critical for the company's continued operation and strategic execution.

Next Steps

• Shareholders will vote on the proposed resolutions at the Annual Meeting on December 21, 2026.
• If approved, the company will proceed with amending its Articles of Incorporation to increase authorized shares.
• The company may issue new warrants and shares under the Equity Purchase Facility Agreement.
• The 2026 Equity Compensation Plan will become effective upon shareholder approval, replacing the 2018 plan.

Key Dates

Recommendation

The filing is procedural and focuses on enabling future flexibility rather than reporting current financial performance. While proposals aim to support Nasdaq compliance and potential capital raises, the significant risk of dilution from increased authorized shares and equity issuances, coupled with the lack of current financial performance indicators, suggests a 'hold' stance. Investors should monitor future capital raise activities and the company's ability to leverage these new authorizations for growth.

Keywords

Annual Meeting, Proxy Statement, Shareholder Vote, Authorized Shares, Equity Compensation Plan, Reverse Stock Split, Warrants, Nasdaq Compliance